Latest news
TD Cowen Maintains Artiva Biotherapeutics(ARTV.US) With Buy Rating, Announces Target Price $11.58 - MoomooMoomoo · Sat, 08 Aug 2026 05:27:04 GMTCertain Stock Options of Artiva Biotherapeutics, Inc. are subject to a Lock-Up Agreement Ending on 7-AUG-2026. - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 00:36:17 GMTArtiva Biotherapeutics (NASDAQ:ARTV) Announces Quarterly Earnings Results - MarketBeatMarketBeat · Fri, 07 Aug 2026 00:25:41 GMTArtiva Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Fri, 07 Aug 2026 00:12:00 GMTArtiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 20:05:00 GMTRA Capital Management Boosts Artiva Biotherapeutics Stake with $412,000 Stock Acquisition - Kalkine MediaKalkine Media · Tue, 28 Jul 2026 21:53:18 GMTArtiva Biotherapeutics Inc (ARTV) Financial Health: Profitability & Balance Sheet Analysis - TradingKeyTradingKey · Mon, 27 Jul 2026 06:35:56 GMTArtiva Biotherapeutics Inc (ARTV) Income Statement - TradingKeyTradingKey · Sun, 26 Jul 2026 02:04:51 GMT